Agilent Technologies (NYSE:A – Free Report) The price target was raised by TD Cowen from $153.00 to $160.00 in a research report published Thursday morning, Benzinga reports. They currently have a buy rating on the medical research company’s stock.
Several other research firms have also recently commented on A. Barclays decreased their price target on Agilent Technologies from $135.00 to $125.00 and gave the company an underweight rating in a report on Friday, May 31. JPMorgan Chase & Co. decreased their price target on Agilent Technologies from $165.00 to $155.00 and gave the stock an overweight rating in a research note on Thursday, May 30. UBS Group decreased their price target on Agilent Technologies from $155.00 to $141.00 and gave the company a neutral rating in a research note on Thursday, May 30. Wolfe Research downgraded Agilent Technologies from an outperform rating to a peer perform rating in a research report on Thursday, June 27. Finally, Evercore ISI raised their price target on Agilent Technologies from $130.00 to $135.00 and gave the company an in-line rating in a research note on Thursday. One investment analyst has rated the stock with a sell rating, six have a hold rating and nine have assigned a buy rating. Based on data from MarketBeat.com, the company has a consensus rating of Moderate Buy and an average price target of $139.53.
Check out our latest stock analysis on Agilent Technologies
Agilent Technologies is up 0.2%
Shares of A-shares opened at $140.22 on Thursday. The company has a 50-day moving average of $133.95 and a 200-day moving average of $138.49. Agilent Technologies has a 12-month low of $96.80 and a 12-month high of $155.35. The company has a market cap of $40.91 billion, a P/E ratio of 33.15, a PEG ratio of 4.86 and a beta of 1.05. The company has a quick ratio of 1.64, a current ratio of 2.15 and a debt-to-equity ratio of 0.34.
Agilent Technologies (NYSE:A – Get Free Report) last released its quarterly earnings results on Wednesday, August 21. The medical research company reported earnings per share of $1.32 for the quarter, beating the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 26.25% and a net margin of 18.84%. The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.56 billion. In the same quarter last year, the company generated earnings per share of $1.43. The company’s quarterly revenue declined 5.6% compared to the same quarter last year. Sell-side analysts expect Agilent Technologies to report earnings per share of $5.24 for the current year.
Insider activity
In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock on Monday, June 3. The shares were sold at an average price of $130.00, for a total value of $254,540.00. Following the completion of the sale, the CEO now owns 25,185 shares of the company’s stock, valued at approximately $3,274,050. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC’s website. In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock on Monday, June 10. The shares were sold at an average price of $133.28, for a total value of $1,999,200.00. Following the transaction, the senior vice president now directly owns 49,486 shares of the company’s stock, valued at approximately $6,595,494.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC’s website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction that occurred on Monday, June 3. The shares were sold at an average price of $130.00, for a total value of $254,540.00. Following the sale, the chief executive officer now directly owns 25,185 shares of the company’s stock, valued at approximately $3,274,050. The disclosure regarding this sale can be found here. In the last three months, insiders have sold 18,916 shares of the company’s stock, valued at $2,527,860. 0.33% of the shares are currently owned by insiders.
Institutional investors comment on Agilent Technologies
Hedge funds and other institutional investors have recently added to or reduced their holdings in the company. International Assets Investment Management LLC acquired a new position in Agilent Technologies in the 4th quarter valued at around $10,595,000. CWM LLC increased its holdings in Agilent Technologies by 12.4% in the 4th quarter. CWM LLC now owns 7,559 shares of the medical research company’s stock valued at $1,051,000 after acquiring an additional 836 shares during the same period. Duality Advisers LP acquired a new position in Agilent Technologies in the 4th quarter valued at $559,000. RWA Wealth Partners LLC acquired a new position in Agilent Technologies in the 4th quarter valued at $258,000. Finally, GAMMA Investing LLC acquired a new position in Agilent Technologies in the 4th quarter valued at $117,000. 87.42% of the shares are currently owned by institutional investors.
About Agilent Technologies
(Get free report)
Agilent Technologies, Inc. provides application-focused solutions for the life sciences, diagnostics and applied chemistry markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography-mass spectrometry systems; gas chromatography systems and components; gas chromatography-mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; Raman spectroscopy; cell analysis plate-based testing; flow cytometers; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software; information management and analysis; laboratory automation and robotic systems; dissolution testing; and vacuum pumps and measurement technologies.
Read more
Get daily news and reviews about Agilent Technologies – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Agilent Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.
